Cargando…
Measurement invariance of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) across four European countries during the COVID-19 pandemic
BACKGROUND: The Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) are self-report measures of major depressive disorder and generalised anxiety disorder. The primary aim of this study was to test for differential item functioning (DIF) on the PHQ-9 and GAD-7 items b...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886334/ https://www.ncbi.nlm.nih.gov/pubmed/35232409 http://dx.doi.org/10.1186/s12888-022-03787-5 |
_version_ | 1784660647440547840 |
---|---|
author | Shevlin, Mark Butter, Sarah McBride, Orla Murphy, Jamie Gibson-Miller, Jilly Hartman, Todd K. Levita, Liat Mason, Liam Martinez, Anton P. McKay, Ryan Stocks, Thomas VA Bennett, Kate M Hyland, Philip Vallieres, Frédérique Valiente, Carmen Vazquez, Carmelo Contreras, Alba Peinado, Vanesa Trucharte, Almudena Bertamini, Marco Panzeri, Anna Bruno, Giovanni Granziol, Umberto Mignemi, Giuseppe Spoto, Andrea Vidotto, Giulio Bentall, Richard P. |
author_facet | Shevlin, Mark Butter, Sarah McBride, Orla Murphy, Jamie Gibson-Miller, Jilly Hartman, Todd K. Levita, Liat Mason, Liam Martinez, Anton P. McKay, Ryan Stocks, Thomas VA Bennett, Kate M Hyland, Philip Vallieres, Frédérique Valiente, Carmen Vazquez, Carmelo Contreras, Alba Peinado, Vanesa Trucharte, Almudena Bertamini, Marco Panzeri, Anna Bruno, Giovanni Granziol, Umberto Mignemi, Giuseppe Spoto, Andrea Vidotto, Giulio Bentall, Richard P. |
author_sort | Shevlin, Mark |
collection | PubMed |
description | BACKGROUND: The Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) are self-report measures of major depressive disorder and generalised anxiety disorder. The primary aim of this study was to test for differential item functioning (DIF) on the PHQ-9 and GAD-7 items based on age, sex (males and females), and country. METHOD: Data from nationally representative surveys in UK, Ireland, Spain, and Italy (combined N = 6,054) were used to fit confirmatory factor analytic and multiple-indictor multiple-causes models. RESULTS: Spain and Italy had higher latent variable means than the UK and Ireland for both anxiety and depression, but there was no evidence for differential items functioning. CONCLUSIONS: The PHQ-9 and GAD-7 scores were found to be unidimensional, reliable, and largely free of DIF in data from four large nationally representative samples of the general population in the UK, Ireland, Italy and Spain. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-022-03787-5. |
format | Online Article Text |
id | pubmed-8886334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88863342022-03-01 Measurement invariance of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) across four European countries during the COVID-19 pandemic Shevlin, Mark Butter, Sarah McBride, Orla Murphy, Jamie Gibson-Miller, Jilly Hartman, Todd K. Levita, Liat Mason, Liam Martinez, Anton P. McKay, Ryan Stocks, Thomas VA Bennett, Kate M Hyland, Philip Vallieres, Frédérique Valiente, Carmen Vazquez, Carmelo Contreras, Alba Peinado, Vanesa Trucharte, Almudena Bertamini, Marco Panzeri, Anna Bruno, Giovanni Granziol, Umberto Mignemi, Giuseppe Spoto, Andrea Vidotto, Giulio Bentall, Richard P. BMC Psychiatry Research BACKGROUND: The Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) are self-report measures of major depressive disorder and generalised anxiety disorder. The primary aim of this study was to test for differential item functioning (DIF) on the PHQ-9 and GAD-7 items based on age, sex (males and females), and country. METHOD: Data from nationally representative surveys in UK, Ireland, Spain, and Italy (combined N = 6,054) were used to fit confirmatory factor analytic and multiple-indictor multiple-causes models. RESULTS: Spain and Italy had higher latent variable means than the UK and Ireland for both anxiety and depression, but there was no evidence for differential items functioning. CONCLUSIONS: The PHQ-9 and GAD-7 scores were found to be unidimensional, reliable, and largely free of DIF in data from four large nationally representative samples of the general population in the UK, Ireland, Italy and Spain. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-022-03787-5. BioMed Central 2022-03-01 /pmc/articles/PMC8886334/ /pubmed/35232409 http://dx.doi.org/10.1186/s12888-022-03787-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Shevlin, Mark Butter, Sarah McBride, Orla Murphy, Jamie Gibson-Miller, Jilly Hartman, Todd K. Levita, Liat Mason, Liam Martinez, Anton P. McKay, Ryan Stocks, Thomas VA Bennett, Kate M Hyland, Philip Vallieres, Frédérique Valiente, Carmen Vazquez, Carmelo Contreras, Alba Peinado, Vanesa Trucharte, Almudena Bertamini, Marco Panzeri, Anna Bruno, Giovanni Granziol, Umberto Mignemi, Giuseppe Spoto, Andrea Vidotto, Giulio Bentall, Richard P. Measurement invariance of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) across four European countries during the COVID-19 pandemic |
title | Measurement invariance of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) across four European countries during the COVID-19 pandemic |
title_full | Measurement invariance of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) across four European countries during the COVID-19 pandemic |
title_fullStr | Measurement invariance of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) across four European countries during the COVID-19 pandemic |
title_full_unstemmed | Measurement invariance of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) across four European countries during the COVID-19 pandemic |
title_short | Measurement invariance of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) across four European countries during the COVID-19 pandemic |
title_sort | measurement invariance of the patient health questionnaire (phq-9) and generalized anxiety disorder scale (gad-7) across four european countries during the covid-19 pandemic |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886334/ https://www.ncbi.nlm.nih.gov/pubmed/35232409 http://dx.doi.org/10.1186/s12888-022-03787-5 |
work_keys_str_mv | AT shevlinmark measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT buttersarah measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT mcbrideorla measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT murphyjamie measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT gibsonmillerjilly measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT hartmantoddk measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT levitaliat measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT masonliam measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT martinezantonp measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT mckayryan measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT stocksthomasva measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT bennettkatem measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT hylandphilip measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT vallieresfrederique measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT valientecarmen measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT vazquezcarmelo measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT contrerasalba measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT peinadovanesa measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT truchartealmudena measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT bertaminimarco measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT panzerianna measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT brunogiovanni measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT granziolumberto measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT mignemigiuseppe measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT spotoandrea measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT vidottogiulio measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic AT bentallrichardp measurementinvarianceofthepatienthealthquestionnairephq9andgeneralizedanxietydisorderscalegad7acrossfoureuropeancountriesduringthecovid19pandemic |